| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL1700022 | 注射用重组抗HER2人源化单克隆抗体偶联美登素衍生物DM1 | HS-630 | Lyophilized | Biological Products(2) | New Drug Application | 2017-05-25 | 浙江海正药业股份有限公司 | Zhejiang Hisun Pharmaceutical Co Ltd | Certificate Issued | 2018-05-08 | view |